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Effectiveness results
Of the 88 patients who underwent an MIP, 3 continued to have persistent hyperparathyroidism after the first procedure, as shown by the high calcium levels in the follow-up period.
In terms of QPTH, 78 patients had true-positive results (correctly predicted cure), 7 patients had false-negative results (wrongly predicting persistent HPT), and 2 had true-negative results (correctly predicting HPT).
These results were used to derive the sensitivity and specificity results of the interventions. For QPTH, the sensitivity was 91.8%, the specificity 66.7%, the PPV 98.7%, and the NPV 22.2%. For same-day PTH, the sensitivity was 100%, the specificity 66.7%, the PPV 98.9%, and the NPV 100%.
The overall accuracy was 90.9% for QPTH and 98.9% for same-day PTH.
The number of patients who underwent unnecessary conversions or reoperation was 7 for the QPTH group and 1 for the same-day PTH group.
One patient was discharged from each group with persistent HTP.
Clinical conclusions
The authors concluded that QPTH estimation is an accurate test, but the false-positive and false-negative rates significantly reduce its effectiveness.
Modelling
A decision analysis tree was used to estimate the costs. Three management strategies were created.
1. QPTH measurement not performed and the patient is discharged from hospital for routine check-up. The decision to reoperate at subsequent admission is made on the basis of postoperative serum calcium results.
2. QPTH measured intraoperatively and the results are made available to the surgeon intraoperatively. The decision to convert to an immediate open bilateral exploration is based on the failure of the QPTH results to decrease to within the normal limits or to less than 50% of the preoperative level at 10 minutes.
3. The measurement of PTH levels in blood samples collected intraoperatively by a routine laboratory run on the day of the operation. The results are made available the same evening in conjunction with a serum result. The decision to reoperate during the same hospital admission is based on the failure of the PTH levels to decrease to the aforementioned criteria, and the failure of the serum calcium level to normalise. The outcome measurement used in the economic analysis was the correct estimation of PTH levels to avoid failed operations.
Measure of benefits used in the economic analysis

Direct costs
No discounting was carried out since the costs were occurred over less than two years. The quantities and the costs were estimated from actual data and were also derived using modelling. The surgical and hospital data were derived from estimates of standard charges in an Australian setting. These costs included hospital admission (one day), operating theatre charges for parathyroidectomy, personnel charges (surgeon, anaesthesiologist and pathologist) for the parathyroid operation, a single PTH assay on a routine laboratory run, a single PTH assay with a dedicated machine (including the amortised capital cost of a dedicated machine, reagents and technician time), and a single estimation of the serum calcium. There was no mention of when the quantities of resources were measured. The price year was not reported.
Statistical analysis of costs
The deterministic costs were presented. A sensitivity analysis identified the areas of uncertainty associated with the estimates.
Indirect Costs
The indirect costs were not considered since the study was conducted from a provider perspective.
Currency
Australian dollars (Aus$).
Sensitivity analysis
Sensitivity analyses were carried out to test the robustness of the cost-effectiveness results, by varying cost assumptions.
Estimated benefits used in the economic analysis
For the first scenario of the model, if no QPTH had been made available and operative decisions had been based solely on the preoperative localisation studies and clinical acumen, 85 of the 88 patients would have been cured at the initial operation. No patient would have undergone an unnecessary conversion to an open procedure.
In the second scenario, two patients would have undergone conversion to an open procedure and would have benefited with presumed care. However, 7 patients would have undergone an unnecessary conversion to an open procedure.
In the third scenario, 3 patients would have had persistent HPT and the procedures in 2 patients would have been failed. However, no patients would have undergone an unnecessary conversion.
Cost results
The total cost was Aus$19,801.19 for intraoperative QPTH and Aus$624.73 for intraoperative PTH plus calcium.
Synthesis of costs and benefits
The benefits and the costs were combined in terms of the cost per one failed operation.
From the sensitivity analysis, if the bed-day costs were doubled to Aus$582.40, the cost-effectiveness of QPTH versus routine PTH plus calcium was Aus$20,406.45 versus Aus$322.47.
If the bed-day costs were quadrupled to Aus$1,164.86 per day, the respective costs would be Aus$21,747 (QPTH) and
